Page last updated: 2024-11-06

phenoxazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Phenoxazine is a heterocyclic compound with a tricyclic structure. It is known for its potential in various applications, including:
* **Synthesis:** It acts as a building block for synthesizing numerous derivatives with diverse biological activities.
* **Dyeing and Pigmentation:** Phenoxazine derivatives exhibit vibrant colors and find applications in dyes and pigments.
* **Medicinal Chemistry:** Its derivatives have been explored for their potential in treating diseases like cancer, bacterial infections, and inflammation.
* **Organic Electronics:** Its unique electronic properties make it relevant in organic electronics, especially for applications like organic light-emitting diodes (OLEDs) and solar cells.
* **Fluorescent Probes:** Its fluorescence properties make it useful as a fluorescent probe in various research areas, including biological imaging and sensing.'

phenoxazine: RN given refers to 10H-phenoxazine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

10H-phenoxazine : A member of the class of phenoxazines that is morpholine which is ortho-fused to two benzene rings at positions 2-3 and 5-6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID67278
CHEMBL ID276850
CHEBI ID94057
SCHEMBL ID7862
SCHEMBL ID3136415
MeSH IDM0117500

Synonyms (45)

Synonym
BIDD:GT0035
phenazoxine
5,4-oxazine
nsc-72990
10h-phenoxazine
inchi=1/c12h9no/c1-3-7-11-9(5-1)13-10-6-2-4-8-12(10)14-11/h1-8,13
135-67-1
nsc72990
phenoxazine
phenoxazine, 97%
phenoxazine, >=99%, purified by sublimation
nsc 72990
ai3-09023
einecs 205-210-8
CHEMBL276850 ,
AKOS003368480
P0899
bdbm50012827
c2zwt499sg ,
unii-c2zwt499sg
BP-20275
FT-0603344
AM20020419
BRD-K53595844-001-01-8
10h-dibenzo[b,e][1,4]oxazine
SCHEMBL7862
2,3;5,6-dibenzo-1,4-oxazine
phenoxazine [mi]
SCHEMBL3136415
J-610038
W-108260
2,3:5,6-dibenzo-1,4-oxazine
DTXSID10159199
mfcd00005014
CS-W009171
CHEBI:94057
SY007779
F14936
AS-17299
Q731009
OL10171
A847765
EN300-218834
Z276157518
HY-34463

Research Excerpts

Overview

Phenoxazines are an important class of heterocycles, emerging in the field of medicinal chemistry. Phenoxazine is a promising scaffold for the development of G4 ligands.

ExcerptReferenceRelevance
"Phenoxazine is a promising scaffold for the development of G4 ligands."( Anticancer activity of G4-targeting phenoxazine derivatives in vitro.
Aralov, AV; Belyaev, ES; Bogomazova, AN; Chistov, AA; Ivanova, OM; Kamzeeva, PN; Khrulev, AA; Lagarkova, MA; Lizunova, SA; Skvortsov, DA; Tsvetkov, VB; Varizhuk, AM; Vasilyeva, LA; Vedekhina, TS, 2022
)
1.72
"Phenoxazines are an important class of heterocycles, which are emerging in the field of medicinal chemistry. "( Advances of Phenoxazines: Synthesis, Reactivity and Their Medicinal Applications.
Katsamakas, S; Sarli, V; Zografos, AL, 2016
)
2.26

Effects

ExcerptReferenceRelevance
"Phenoxazine has been widely used for improving duplex-forming abilities."( Oligonucleotides Containing Phenoxazine Artificial Nucleobases: Triplex-Forming Abilities and Fluorescence Properties.
Fujii, A; Kishimoto, Y; Nakagawa, O; Nakatsuji, Y; Nozaki, N; Obika, S, 2020
)
1.57

Treatment

ExcerptReferenceRelevance
"Phenoxazine treatment resulted in the loss of resistance markers to an extent of 8-63% in all the strains tested, and the disappearance of plasmid DNA in phenoxazine sensitive colonies was evidenced by agarose gel electrophoresis."( Plasmid loss in plasmid-carrying strains of Escherichia coli treated with phenoxazines and an approach to study their DNA binding properties.
Chandramouli, KH; D'Souza, CJ; Thimmaiah, KN, 2008
)
1.3

Toxicity

ExcerptReferenceRelevance
"The combination of cytotoxic copper-thiosemicarbazone complexes with phenoxazines results in an up to 50-fold enhancement in the cytotoxic potential of the thiosemicarbazone against the MCF-7 human breast adenocarcinoma cell line over the effect attributable to drug additivity-allowing minimization of the more toxic copper-thiosemicarbazone component of the therapy."( Increased generation of intracellular reactive oxygen species initiates selective cytotoxicity against the MCF-7 cell line resultant from redox active combination therapy using copper-thiosemicarbazone complexes.
Akladios, FN; Andrew, SD; Parkinson, CJ, 2016
)
0.67

Compound-Compound Interactions

ExcerptReferenceRelevance
"The aim of this study was to investigate the anticancer effects of the phenoxazine derivatives, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one (Phx-1), 3-amino-1,4alpha-dihydro-4alpha,8-dimethyl-2H-phenoxazine-2-one (Phx-2), and 2-aminophenoxazine-3-one (Phx-3) on human pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2, in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of the tumor necrosis factor superfamily of cytokines."( Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2.
Abe, A; Akiyama, S; Che, XF; Imaizumi, K; Kato, S; Mizuguchi, J; Odawara, M; Shirato, K; Tomoda, A; Toyota, H, 2006
)
0.88

Dosage Studied

ExcerptRelevanceReference
" The cultures and controls were incubated at 28 degrees C with shaking and dosed with 16."( Oxidation of phenothiazine and phenoxazine by Cunninghamella elegans.
Freeman, JP; Heinze, TM; Moody, JD; Parshikov, IA; Sutherland, JB; Williams, AJ; Zhang, D, 2001
)
0.6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
ferroptosis inhibitorAny substance that inhibits the process of ferroptosis (a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides) in organisms.
radical scavengerA role played by a substance that can react readily with, and thereby eliminate, radicals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phenoxazine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tubulin alpha-1A chainSus scrofa (pig)IC50 (µMol)10.00000.00672.160310.0000AID605956
Tubulin beta chainSus scrofa (pig)IC50 (µMol)10.00000.00672.137410.0000AID605956
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)IC50 (µMol)0.32000.00462.018210.0000AID6824
Prostaglandin G/H synthase 2 Rattus norvegicus (Norway rat)IC50 (µMol)0.35000.00291.786810.0000AID160880
Prostaglandin G/H synthase 1 Rattus norvegicus (Norway rat)IC50 (µMol)0.35000.00291.823210.0000AID160880
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID293674Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis inhibition time at 13.9 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID605844Antiproliferative activity against human K562 cells after 48 hrs by hemocytometric analysis2011Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12
N-benzoylated phenoxazines and phenothiazines: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
AID293650Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis time at 13.9 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID605956Inhibition of pig tubulin polymerization determined after 45 mins at 37 degC by turbidimetric analysis2011Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12
N-benzoylated phenoxazines and phenothiazines: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
AID293675Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis inhibition time at 15.5 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID160880In vitro inhibition of Prostaglandin G/H synthase pathway in rat basophilic leukemia (RBL-1) cells1990Journal of medicinal chemistry, Jul, Volume: 33, Issue:7
1,2-Dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with antiinflammatory activity.
AID1426445Antiproliferative activity against human K562 cells after 48 hrs by Alamar blue dye based neubauer hemocytometer method2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
N-Heterocyclic (4-Phenylpiperazin-1-yl)methanones Derived from Phenoxazine and Phenothiazine as Highly Potent Inhibitors of Tubulin Polymerization.
AID6824In vitro inhibition of 5-lipoxygenase pathway in rat basophilic leukemia (RBL-1) cells1990Journal of medicinal chemistry, Jul, Volume: 33, Issue:7
1,2-Dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with antiinflammatory activity.
AID1426446Inhibition of porcine tubulin polymerization after 45 mins by turbidometric method2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
N-Heterocyclic (4-Phenylpiperazin-1-yl)methanones Derived from Phenoxazine and Phenothiazine as Highly Potent Inhibitors of Tubulin Polymerization.
AID293671Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis inhibition time at 9.27 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID293651Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis time at 15.5 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID293649Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis time at 12.4 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID293648Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis time at 10.8 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID673777Cytotoxicity in UV-irradiated human U937 cells exposed to photosensitizer for 2 hrs before irradiation for 20 mins by WST-1 assay2012ACS medicinal chemistry letters, Apr-12, Volume: 3, Issue:4
Type 1 Phototherapeutic Agents. 2. Cancer Cell Viability and ESR Studies of Tricyclic Diarylamines.
AID293647Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis time at 9.27 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID293672Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis inhibition time at 10.8 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID293673Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis inhibition time at 12.4 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (125)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (10.40)18.7374
1990's12 (9.60)18.2507
2000's43 (34.40)29.6817
2010's42 (33.60)24.3611
2020's15 (12.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.66 (24.57)
Research Supply Index4.90 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index55.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other131 (98.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]